Fundraising Fox
🦊/People
Sign in

Marc Tessier-Lavigne

Unicorn founder

Founder at Denali Therapeutics · Chairman & Chief Executive Officer at Xaira Therapeutics

United States

FoundedDenali Therapeutics$3.9BXaira Therapeutics

Find your path to Marc

2,762 people in our graph share verified history with Marc — schools, employers, funds. One of them is your warm intro.

Deep NisharunlockedMarc: together at Stanford University (2015–2018)
×7Marc: together at Stanford University
×2Marc: together at Denali Therapeutics
Marc: together at Juno Therapeutics, Inc.

Chairman & Chief Executive Officer at Xaira Therapeutics

Intro paths

→

In turn, Marc can intro founders to Xaira Therapeutics's investors below.

Xaira Therapeutics's investors · 8

ARCH Venture PartnersChicago · $50K – $250M checks · since 2024Breyer CapitalAustin · $500K – $10M checksF-Prime CapitalCambridge · $3M – $10M checksForesite CapitalWest Hollywood · since 2024Longwood FundBostonMenlo VenturesSan Francisco · $1M – $20M checksNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2024Vedanta CapitalNew York

Co-founders at Xaira Therapeutics

HK
Hetu KamisettyFounder

Experience

  1. Xaira TherapeuticsChief Executive Officercurrent2024 — presentSan Francisco Bay Area
  2. Stanford UniversityProfessor of Biologycurrent2023 — present
  3. Stanford UniversityPresident and Bing Presidential Professor2016 — 2023
  4. Denali TherapeuticsMember, Board of Directors2015 — 2025
  5. Denali TherapeuticsChairman2015 — 2016
  6. RegeneronMember, Board of Directors2011 — 2023
  7. Agios PharmaceuticalsChairman2015 — 2016
  8. Agios PharmaceuticalsMember, Board of Directors2011 — 2016
  9. Juno Therapeutics, Inc.Member, Board of Directors2014 — 2016
  10. The Rockefeller UniversityPresident and Carson Family Professor2011 — 2016
  11. PFIZER INC.Member, Board of Directors2011 — 2015
  12. GenentechChief Scientific Officer and Executive Vice President, Research2009 — 2011
  13. GenentechExecutive Vice President, Research Drug Discovery2008 — 2009
  14. GenentechSenior Vice President, Research Drug Discovery2003 — 2008
  15. Stanford UniversityProfessor of Biology2001 — 2003
  16. Howard Hughes Medical Institute (HHMI)Investigator1997 — 2003
  17. Howard Hughes Medical Institute (HHMI)Assistant Investigator1994 — 1997
  18. RenovisCo-founder and member, Scientific Advisory Board2000 — 2003
  19. University of California, San FranciscoProfessor of Anatomy and of Biochemistry and Biophysics1997 — 2001
  20. University of California, San FranciscoAssociate Professor of Anatomy1995 — 1997
  21. University of California, San FranciscoAssistant Professor of Anatomy1991 — 1995
  22. ExelixisMember, Scientific Advisory Board1995 — 2000
  23. Columbia UniversityPostdoctoral Fellow1987 — 1991
  24. University College LondonPostdoctoral Fellow1986 — 1987

Frequently asked questions

Who is Marc Tessier-Lavigne?
Founder at Xaira Therapeutics
Where does Marc Tessier-Lavigne work?
Marc Tessier-Lavigne is Founder of Denali Therapeutics and Chairman & Chief Executive Officer at Xaira Therapeutics.
What companies did Marc Tessier-Lavigne found?
Marc Tessier-Lavigne founded Denali Therapeutics, Xaira Therapeutics.
Where did Marc Tessier-Lavigne go to school?
Marc Tessier-Lavigne studied at UCL (Doctor of Philosophy - PhD, Physiology); University of Oxford (Bachelor of Arts - BA, Philosophy and Physiology); McGill University (Bachelor of Science - BS, Physics).

Same school

Shared employers